–
Статьи в журналах
-
- 2016 MAESTRO: A randomized, double-blind phase III study of evofosfamide (Evo) in combination with gemcitabine (Gem) in previously untreated patients (pts) with metastatic or locally advanced unresectable pancreatic ductal adenocarcinoma (PDAC)
- Van Cutsem Eric, Lenz Heinz-Josef, Furuse Junji, Tabernero Josep, Heinemann Volker, Ioka Tatsuya, Bazin Igor, Ueno Makoto, Csoszi Tibor, Wasan Harpreet, Melichar Bohuslav, Karasek Petr, Macarulla Teresa Mercade, Guillen Carmen, Kalinka-Warzocha Ewa, Horvath Zsolt, Prenen Hans, Schlichting Michael, Ibrahim Ayman, Bendell Johanna C.
- в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 34, № 15 DOI